116140-19-3 Usage
Description
1,2,3,4-Tetrahydroisoquinoline-4-carboxylic acid is a chemical compound with the molecular formula C11H13NO2, belonging to the isoquinoline derivative class. It is recognized for its neuroprotective and antioxidant properties, positioning it as a promising candidate in the pharmaceutical industry for the synthesis of bioactive compounds and the development of drugs targeting neurodegenerative diseases.
Uses
Used in Pharmaceutical Industry:
1,2,3,4-Tetrahydroisoquinoline-4-carboxylic acid is used as a key intermediate for the synthesis of various bioactive compounds due to its unique chemical structure and properties.
Used in Drug Development for Neurodegenerative Diseases:
1,2,3,4-Tetrahydroisoquinoline-4-carboxylic acid is used as a potential therapeutic agent for the treatment of neurodegenerative diseases, leveraging its neuroprotective and antioxidant capabilities to mitigate disease progression.
Used in Medicinal Chemistry and Drug Discovery:
1,2,3,4-Tetrahydroisoquinoline-4-carboxylic acid is utilized as a building block for the synthesis of novel drugs, contributing to the advancement of pharmaceutical research and the discovery of new therapeutic agents with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 116140-19-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,1,4 and 0 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 116140-19:
(8*1)+(7*1)+(6*6)+(5*1)+(4*4)+(3*0)+(2*1)+(1*9)=83
83 % 10 = 3
So 116140-19-3 is a valid CAS Registry Number.
116140-19-3Relevant articles and documents
A Unified Synthesis of Bifunctional 4-Substituted-1,2,3,4-tetrahydroisoquinoline Derivatives
Bernabeu, M. Carmen,Diaz, Jose Luis,Jimenez, Oscar,Lavilla, Rodolfo
, p. 137 - 149 (2007/10/03)
Starting from a single, commercially available bromoisoquinoline, convenient (multigram) syntheses of 4-substituted-1,2,3, 4-tetrahydroisoquinoline derivatives have been developed. The compounds thus prepared show suitable substitution patterns for further derivatization and constitute a new family of compounds of potential pharmacological interest.
